Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytori Therapeutics Inc (NASDAQ:CYTX)

1.54
Delayed Data
As of Dec 02
 +0.04 / +2.67%
Today’s Change
1.49
Today|||52-Week Range
5.91
-44.50%
Year-to-Date

Today’s Trading

Previous close1.50
Today’s open1.49
Day’s range1.49 - 1.56
Volume126,144
Average volume (3 months)114,180
Market cap$31.6M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+70.83%
Earnings growth (this year)+37.14%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales5.38
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
MGCDMGC Diagnostics Corp+0.06+0.78%
ARDMAradigm Corp-0.12-5.24%
NVCNNeovasc Inc+0.35+67.38%
DXRDaxor Corp-0.55-6.11%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.4M
Net profit margin-401.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Marc H. Hedrick
CFO, Vice President &
Head-Investor Relations
Tiago Girão
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs